1.
Clin Case Rep
; 7(8): 1585-1590, 2019 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31428397
RESUMO
Platelet to lymphocyte ratio (PLR) is a candidate prognostic marker for metastatic castration-resistant prostate cancer patients receiving abiraterone acetate and evidence demonstrates that a high PLR is associated with poor survival. More studies are required to verify current findings and establish a definite cutoff point.